Know Cancer

or
forgot password

Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France


N/A
N/A
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France


Inclusion Criteria:



- Patients suffering from initial breast cancer, treated with Faslodex, treatment which
was stopped during 2007

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

Evaluate Faslodex therapeutic strategy and treatment duration

Outcome Time Frame:

At the end of the study

Safety Issue:

No

Principal Investigator

Alain FLINOIS

Investigator Role:

Principal Investigator

Investigator Affiliation:

TNS Healthcare - France138, avenue Marx Dormoy92120 Montrouge

Authority:

France: Haute Autorité de Santé Transparency Commission

Study ID:

NIS-OFR-FAS-2007/1

NCT ID:

NCT00681369

Start Date:

May 2007

Completion Date:

June 2007

Related Keywords:

  • Breast Cancer
  • breast cancer
  • fulvestrant
  • longitudinal study
  • France
  • Breast Neoplasms
  • Stress, Psychological

Name

Location